On October 12th, Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited held a strategic cooperation meeting with Tianjin University of Traditional Chinese Medicine and Modern Traditional Chinese Medicine Haihe Laboratory in Da Ren Tang Building.

Gao Xiumei, Vice Chairman of Tianjin CPPCC and President of Tianjin University of Traditional Chinese Medicine, Zhang Junhua, Executive Deputy Director of Modern Traditional Chinese Medicine Haihe Laboratory and Dean of Institute of Traditional Chinese Medicine of Tianjin University of Traditional Chinese Medicine, as well as experts and professors in various fields, Zhang Mingrui, President of Tianjin Pharmaceutical Holdings Co., Ltd., Party Secretary and Chairman of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, Wang Lei, Deputy Secretary and General Manager of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, and relevant responsible comrades of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited attended the meeting.

At the meeting, Wang Lei, Deputy Party Secretary and General Manager of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, made a welcome speech and introduced the construction and development of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited. Experts and professors from Tianjin University of Traditional Chinese Medicine reviewed the overall strategic cooperation, scientific research cooperation and party building cooperation with Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, and shared the phased research results of China Heart Products Development Plan.

Zhang Mingrui, President of Tianjin Pharmaceutical Holdings Co., Ltd., Party Secretary and Chairman of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, thanked Tianjin University of Traditional Chinese Medicine and Modern Traditional Chinese Medicine Haihe Laboratory for their guidance and assistance in the development of the traditional Chinese medicine sector of Tianjin Pharmaceutical Darentang, and put forward the scientific and technological innovation needs and new expectations of China heart products.

Professor Gao Xiumei and Professor Zhang Junhua introduced the advantages of enterprises and universities focusing around the characteristics and needs of enterprise products, and gave guidance on the direction of scientific and technological innovation and key research tasks, proposed to attach importance to collaborative innovation of clinical and basic research, strengthen the combination of advantages and disadvantages, and the combination of old and new, and put forward differentiated development strategies around the high-quality development of China heart products, so as to maximize the therapeutic advantages of different products and better serve the strategic needs of enterprises and the health needs of patients.

The parties also deeply discussed the advantages, working path and future research breakthrough point of the secondary development of key varieties of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited.

In the future, Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited will, under the guidance and support of Tianjin Pharmaceutical Holdings Co., Ltd., continue to expand its diversified scientific research cooperation with Tianjin University of Traditional Chinese Medicine and Modern Traditional Chinese Medicine Haihe Laboratory in the fields of innovative drug research and development, secondary development of large varieties of traditional Chinese medicine, and application research of innovative technologies, so as to realize the integration of Industry-University-Research and jointly help build a healthy China and a healthy Tianjin.